Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA 286:78-82, Akkerhuis,K.M.,et al, 2001
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001
Extracranial Carotid Stenosis
NEJM 345:1113-1118, Sacco,R., 2001
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999
Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999
Brain Infarction Following 5-Fluorouracil and Cisplatin Therapy
Neurol 52:899-901, Amrani,M.E.,et al, 1998
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion
JAMA 280:1055-1060, 10931998., Grubb,R.L.,et al, 1998
Tissue-Type Plasminogen Activator Should Not be Used in Acute Ischemic Stroke
Arch Neurol 53:1306-1308, Riggs,J.E., 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996
Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995
Guidelines for the Management of Patients with Acute Ischemic Stroke
Stroke 25:1901-1914, Adams,H.P.,et al, 1994
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994
Thromboendartectomy of the Symptomatic Occluded Internal Carotid Artery
J Neurosurg 76:752-758, McCormick,P.W.,et al, 1992
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Management Dilemmas in Carotid Artery Disease
Patient Care 24:14-46, Adams,H.P.,et al, 1990
Anticoagulation:Is There Still a Role in Atherothrombotic Stroke
Stroke 21:820-824, Estol,C.J.&Pessin,M.S., 1990
Feasibility of Percutaneous Transluminal Angioplasty for Carotid Artery Stensosis
JNNP 53:238-243, Brown,M.M.,et al, 1990
Stroke-1989 Recommendations on Stroke Prevention
Diagnosis, and Therapy, Report of the WHO Force on Stroke and CV Disorders, Stroke 20:1407-143189., , 1989
Atherosclerosis:Current Concepts on Pathogenesis and Interventional Therapies
Ann Neurol 26:3-12, Yatsu,F.M.&Fisher,M., 1989
Controversies in the Management of Cerebral Vascular Disease
Neurol 38:1609-1616, Scheinberg,P., 1988
Carotid Endarterectomy, Clinical Results in a Community-Based Teaching Hospital
Stroke 19:1323-1327, Friedmann,P.,et al, 1988
Prognosis of High-Risk Patients with Nonoperated Symptomatic Extracranial Carotid Tight Stenosis
Stroke 19:108-111, Bogousslavsky,J.,et al, 1988
Aspirin All Round
BMJ 296:307-308, Orme,M., 1988
Secondary Prevention of Vascular Disease by Prolonged Antiplatelet Treatment
Antiplatelet Trailists'Collaboration, BMJ 296:320-3311988., , 1988
Medical Treatment of Transient Ischemic Attacks:Does it Influence Mortality
Stroke 19:397-400, Ramirez-Lassepas,M.&Cipolle,R.J., 1988
A Prospective Analysis of 142 Carotid Endarterectomies for Occlusive Vascular Disease, 1979-1985
J Neurosurg 67:540-544, Zeiger,H.E.,et al, 1987
Thrombolytic Therapy in Stroke:Possibilities & Hazards
Stroke 17:595-607, DelZoppo,G.J.,et al, 1986
Hemorrhagic Complications of Long-Term Anticoagulant Therapy for Ischemic Cerebral Vascular Disease
Stroke 17:111-116, Levine,J.&Hirsh,J., 1986
Clinical & Angiographic Features of Carotid Circulation Thrombus
Neurol 36:518-523, Pessin,M.S.,et al, 1986
Carotid Endarterectomy-An Expression of Concern
Stroke 15:941-943, Barnett,H.J.,et al, 1984
The Role of the Neurologist in the Decline of Stroke
Ann Neurol 14:1-7, Whisnant,J.P., 1983
Prevention of Recurrent Stroke
Jr. , et al, Stroke 12:731-73581., Leonberg,S.C., 1981
Carotid Endarterectomy:A Prospective Study of Its Efficacy & Safety
Medicine 60:298-309, Allen,G.S.,et al, 1981
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977
Carotid Endarterectomies & TIA's
Lancet 51, 1974. (Jan) ., , 1974
Newer Concepts of Cerebral Vascular Disease
Med Clin North Am 54:1970., Meyer,J., 1970
Atherosclerotic CVD-Its Nature & Management
Am J Med 46:763, Heyden,S.,et al, 1969
MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025